Cargando…

Activation-induced cytidine deaminase overexpression in double-hit lymphoma: potential target for novel anticancer therapy

Activation-induced cytidine deaminase (AID) is one kind of the mutant enzymes, which target regulating the immunoglobulin (Ig) gene in Burkitt’s lymphoma to initiate class switch recombination (CSR), resulting in c-Myc chromosomal translocation. However, it is not clear that whether AID induces c-My...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Jingcheng, Shi, Yifen, Zhao, Mingzhe, Hu, Huixian, Huang, He
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7447639/
https://www.ncbi.nlm.nih.gov/pubmed/32843697
http://dx.doi.org/10.1038/s41598-020-71058-y
_version_ 1783574343323746304
author Zhang, Jingcheng
Shi, Yifen
Zhao, Mingzhe
Hu, Huixian
Huang, He
author_facet Zhang, Jingcheng
Shi, Yifen
Zhao, Mingzhe
Hu, Huixian
Huang, He
author_sort Zhang, Jingcheng
collection PubMed
description Activation-induced cytidine deaminase (AID) is one kind of the mutant enzymes, which target regulating the immunoglobulin (Ig) gene in Burkitt’s lymphoma to initiate class switch recombination (CSR), resulting in c-Myc chromosomal translocation. However, it is not clear that whether AID induces c-Myc/IgH translocation in double-hit lymphoma (DHL) with c-Myc gene translocation. In this study, the AID in DHL tissues and classical diffuse large b-cell lymphoma (DLBCL) tissues were compared. The results suggested that AID is of important value in predicting DHL, stronger CSR of AID was observed in DHL patients, which exhibited AID overexpression and c-Myc gene translocation of DHL after CSR induction. It is concluded that AID directly induces CSR in DHL and may result in c-Myc gene translocation. Targeting AID may be a good treatment regimen for DHL.
format Online
Article
Text
id pubmed-7447639
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-74476392020-08-26 Activation-induced cytidine deaminase overexpression in double-hit lymphoma: potential target for novel anticancer therapy Zhang, Jingcheng Shi, Yifen Zhao, Mingzhe Hu, Huixian Huang, He Sci Rep Article Activation-induced cytidine deaminase (AID) is one kind of the mutant enzymes, which target regulating the immunoglobulin (Ig) gene in Burkitt’s lymphoma to initiate class switch recombination (CSR), resulting in c-Myc chromosomal translocation. However, it is not clear that whether AID induces c-Myc/IgH translocation in double-hit lymphoma (DHL) with c-Myc gene translocation. In this study, the AID in DHL tissues and classical diffuse large b-cell lymphoma (DLBCL) tissues were compared. The results suggested that AID is of important value in predicting DHL, stronger CSR of AID was observed in DHL patients, which exhibited AID overexpression and c-Myc gene translocation of DHL after CSR induction. It is concluded that AID directly induces CSR in DHL and may result in c-Myc gene translocation. Targeting AID may be a good treatment regimen for DHL. Nature Publishing Group UK 2020-08-25 /pmc/articles/PMC7447639/ /pubmed/32843697 http://dx.doi.org/10.1038/s41598-020-71058-y Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Zhang, Jingcheng
Shi, Yifen
Zhao, Mingzhe
Hu, Huixian
Huang, He
Activation-induced cytidine deaminase overexpression in double-hit lymphoma: potential target for novel anticancer therapy
title Activation-induced cytidine deaminase overexpression in double-hit lymphoma: potential target for novel anticancer therapy
title_full Activation-induced cytidine deaminase overexpression in double-hit lymphoma: potential target for novel anticancer therapy
title_fullStr Activation-induced cytidine deaminase overexpression in double-hit lymphoma: potential target for novel anticancer therapy
title_full_unstemmed Activation-induced cytidine deaminase overexpression in double-hit lymphoma: potential target for novel anticancer therapy
title_short Activation-induced cytidine deaminase overexpression in double-hit lymphoma: potential target for novel anticancer therapy
title_sort activation-induced cytidine deaminase overexpression in double-hit lymphoma: potential target for novel anticancer therapy
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7447639/
https://www.ncbi.nlm.nih.gov/pubmed/32843697
http://dx.doi.org/10.1038/s41598-020-71058-y
work_keys_str_mv AT zhangjingcheng activationinducedcytidinedeaminaseoverexpressionindoublehitlymphomapotentialtargetfornovelanticancertherapy
AT shiyifen activationinducedcytidinedeaminaseoverexpressionindoublehitlymphomapotentialtargetfornovelanticancertherapy
AT zhaomingzhe activationinducedcytidinedeaminaseoverexpressionindoublehitlymphomapotentialtargetfornovelanticancertherapy
AT huhuixian activationinducedcytidinedeaminaseoverexpressionindoublehitlymphomapotentialtargetfornovelanticancertherapy
AT huanghe activationinducedcytidinedeaminaseoverexpressionindoublehitlymphomapotentialtargetfornovelanticancertherapy